U2AF1 and myelodysplastic syndrome: U2AF1 gene mutations, observed in less than 10% of patients [36], have been described mainly in MDS patients characterized by multilineage dysplasia and excess blasts and showed inferior survival and an increased risk of leukemic evolution [37,40,46].